top of page

Insights and News Curated for Life Science Experts by Life Science Experts....

Go back to...
JMG Logo transparent.png
Executive Spotlights

Mercy BioAnalytics Raises $41M in Series A Financing to Advance Novel Mercy Halo Liquid Biopsy

Natick, MA, April 3, 2023 (Business Wire) -- Mercy BioAnalytics, Inc., a pioneer in extracellular vesicle-based liquid biopsies for the early detection of cancer, today announced it has closed a $41 million Series A financing round. The oversubscribed financing was led by Novalis LifeSciences, with participation from Sozo Ventures, Hatteras Venture Partners, iSelect Fund, American Cancer Society BrightEdge, and Broadway Angels, an all-women venture capital group. The round also included strategic investments from Labcorp and Bruker, in addition to strong participation from existing investors.


Read full article here.

Recent Posts

See All

Comments


Life Science Headlines

© 2024 by Jacobs Management Group, Inc.

​

Privacy Policy

​

bottom of page